1
|
Unger H, Kangethe RT, Liaqat F, Viljoen GJ. Advances in Irradiated Livestock Vaccine Research and Production Addressing the Unmet Needs for Farmers and Veterinary Services in FAO/IAEA Member States. Front Immunol 2022; 13:853874. [PMID: 35418985 PMCID: PMC8997582 DOI: 10.3389/fimmu.2022.853874] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2022] [Accepted: 03/07/2022] [Indexed: 12/13/2022] Open
Abstract
The Animal Production and Health section (APH) of the Joint FAO/IAEA Centre of Nuclear Techniques in Food and Agriculture at the International Atomic Energy Agency has over the last 58 years provided technical and scientific support to more than 100 countries through co-ordinated research activities and technical co-operation projects in peaceful uses of nuclear technologies. A key component of this support has been the development of irradiated vaccines targeting diseases that are endemic to participating countries. APH laboratories has over the last decade developed new techniques and has put in place a framework that allows researchers from participating member states to develop relevant vaccines targeting local diseases while using irradiation as a tool for improving livestock resources.
Collapse
Affiliation(s)
- Hermann Unger
- Animal Production and Health Section, Joint FAO/IAEA Centre of Nuclear Techniques in Food and Agriculture, Department of Nuclear Sciences and Applications, International Atomic Energy Agency (IAEA), Vienna, Austria
| | - Richard T Kangethe
- Animal Production and Health Section, Joint FAO/IAEA Centre of Nuclear Techniques in Food and Agriculture, Department of Nuclear Sciences and Applications, International Atomic Energy Agency (IAEA), Vienna, Austria
| | - Fatima Liaqat
- Animal Production and Health Section, Joint FAO/IAEA Centre of Nuclear Techniques in Food and Agriculture, Department of Nuclear Sciences and Applications, International Atomic Energy Agency (IAEA), Vienna, Austria
| | - Gerrit J Viljoen
- Animal Production and Health Section, Joint FAO/IAEA Centre of Nuclear Techniques in Food and Agriculture, Department of Nuclear Sciences and Applications, International Atomic Energy Agency (IAEA), Vienna, Austria
| |
Collapse
|
2
|
Sartori GP, da Costa A, Macarini FLDS, Mariano DOC, Pimenta DC, Spencer PJ, Nali LHDS, Galisteo AJ. Characterization and evaluation of the enzymatic activity of tetanus toxin submitted to cobalt-60 gamma radiation. J Venom Anim Toxins Incl Trop Dis 2021; 27:e20200140. [PMID: 33995513 PMCID: PMC8092855 DOI: 10.1590/1678-9199-jvatitd-2020-0140] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2020] [Accepted: 01/25/2021] [Indexed: 11/29/2022] Open
Abstract
BACKGROUND Tetanus toxin blocks the release of the inhibitory neurotransmitters in the central nervous system and causes tetanus and its main form of prevention is through vaccination. The vaccine is produced by inactivation of tetanus toxin with formaldehyde, which may cause side effects. An alternative way is the use of ionizing radiation for inactivation of the toxin and also to improve the potential immunogenic response and to reduce the post-vaccination side effects. Therefore, the aim of this study was to characterize the tetanus toxin structure after different doses of ionizing radiation of 60Co. METHODS Irradiated and native tetanus toxin was characterized by SDS PAGE in reducing and non-reducing conditions and MALD-TOF. Enzymatic activity was measured by FRET substrate. Also, antigenic properties were assessed by ELISA and Western Blot data. RESULTS Characterization analysis revealed gradual modification on the tetanus toxin structure according to doses increase. Also, fragmentation and possible aggregations of the protein fragments were observed in higher doses. In the analysis of peptide preservation by enzymatic digestion and mass spectrometry, there was a slight modification in the identification up to the dose of 4 kGy. At subsequent doses, peptide identification was minimal. The analysis of the enzymatic activity by fluorescence showed 35 % attenuation in the activity even at higher doses. In the antigenic evaluation, anti-tetanus toxin antibodies were detected against the irradiated toxins at the different doses, with a gradual decrease as the dose increased, but remaining at satisfactory levels. CONCLUSION Ionizing radiation promoted structural changes in the tetanus toxin such as fragmentation and/or aggregation and attenuation of enzymatic activity as the dose increased, but antigenic recognition of the toxin remained at good levels indicating its possible use as an immunogen. However, studies of enzymatic activity of tetanus toxin irradiated with doses above 8 kGy should be further analyzed.
Collapse
Affiliation(s)
- Giselle Pacifico Sartori
- Laboratory of Protozoology, Institute of Tropical Medicine,
University of São Paulo (IMT/FMUSP), São Paulo, SP, Brazil
| | - Andréa da Costa
- Laboratory of Protozoology, Institute of Tropical Medicine,
University of São Paulo (IMT/FMUSP), São Paulo, SP, Brazil
| | | | | | | | - Patrick Jack Spencer
- Biotechnology Center, Nuclear and Energy Research Institute
(IPEN/CNEN/SP), São Paulo, SP, Brazil
| | | | - Andrés Jimenez Galisteo
- Laboratory of Protozoology, Institute of Tropical Medicine,
University of São Paulo (IMT/FMUSP), São Paulo, SP, Brazil
- LIM49, Hospital das Clínicas HCFMUSP, School of Medicine, University
of São Paulo, São Paulo, SP, Brazil
| |
Collapse
|
3
|
Archundia IG, de la Rosa G, Olvera F, Calderón A, Benard-Valle M, Alagón A, Corzo G. Assessment of neutralization of Micrurus venoms with a blend of anti-Micrurus tener and anti-ScNtx antibodies. Vaccine 2021; 39:1000-1006. [PMID: 33423840 DOI: 10.1016/j.vaccine.2020.12.052] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2020] [Revised: 12/11/2020] [Accepted: 12/14/2020] [Indexed: 02/02/2023]
Abstract
BACKGROUND Micrurus venoms contain two main groups of toxic protein components: short-chain α-neurotoxins (SNtx) and phospholipases type A2 (PLA2). In North America, generally, the Micrurus venoms have low abundance of SNtx compared to that of PLA2s; however, both are highly toxic to mammals, and consequently both can play a major role in the envenomation processes. Concerning the commercial horse-derived antivenoms against Micrurus from the North America region, they contain a relatively large amount of antibodies against PLA2s, and a low content of antibodies against short chain α-neurotoxins. This is mainly due to the lower relative abundance of SNtxs, and also to its poor immunogenicity due to their size and nature. Hence, Micrurus antivenoms made in North America usually present low neutralizing capacity towards Micrurus venoms whose lethality depend largely on short chain α-neurotoxins, such as South American Micrurus species. METHODS Horses were hyperimmunized with either the venom of M. tener (PLA2-predominant) or a recombinant short-chain consensus α-neurotoxin (ScNtx). Then, the combination of the two monospecific horse antibodies (anti-M. tener and anti-ScNtx) was used to test their efficacy against eleven Micrurus venoms. RESULTS The blend of anti-M. tener and anti-ScNtx antibodies had a better capacity to neutralize the lethality of diverse species from North, Central and South American Micrurus venoms. The antibodies combination neutralized both the ScNtx and ten out of eleven Micrurus venom tested, and particularly, it neutralized the venoms of M. distans and M. laticollaris that were neither neutralized by monospecific anti-M. tener nor anti-ScNtx. CONCLUSIONS These results provide a proof-of-principle for using recombinant immunogens to enrich poor or even non-neutralizing antisera against elapid venoms containing short chain α-neurotoxins to develop antivenoms with higher effectiveness and broader neutralizing capacity.
Collapse
Affiliation(s)
- Irving G Archundia
- Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología - UNAM, Av. Universidad 2001, Cuernavaca, Morelos 62210, Mexico
| | - Guillermo de la Rosa
- The Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario M5S3E1, Canada.
| | - Felipe Olvera
- Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología - UNAM, Av. Universidad 2001, Cuernavaca, Morelos 62210, Mexico
| | - Arlene Calderón
- Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología - UNAM, Av. Universidad 2001, Cuernavaca, Morelos 62210, Mexico
| | - Melisa Benard-Valle
- Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología - UNAM, Av. Universidad 2001, Cuernavaca, Morelos 62210, Mexico
| | - Alejandro Alagón
- Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología - UNAM, Av. Universidad 2001, Cuernavaca, Morelos 62210, Mexico
| | - Gerardo Corzo
- Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología - UNAM, Av. Universidad 2001, Cuernavaca, Morelos 62210, Mexico.
| |
Collapse
|
4
|
Coelho Thomazi GO, da Costa A, Rodrigues JP, Alves GJ, Prezotto Neto JP, de Oliveira Turíbio T, Rocha AM, da Silva Aires R, Seibert CS, Spencer PJ, Galisteo Júnior AJ, de Andrade Júnior HF, do Nascimento N. Paratrygon aiereba irradiated anti-mucus serum reduce edematogenic activity induced in experimental model. Toxicon 2020; 178:13-19. [PMID: 32067999 DOI: 10.1016/j.toxicon.2020.02.012] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2019] [Revised: 02/09/2020] [Accepted: 02/11/2020] [Indexed: 11/17/2022]
Abstract
Accidents by freshwater stingrays are common in northern Brazil, there is no specific therapy for high morbidity and local tissue destruction. The irradiation of venoms and toxins by ionizing radiation has been used to produce appropriate immunogens for the production of antisera. We planned to study the efficacy of stinging mucus irradiation in the production of antisera, with serum neutralization assays of edematogenic activity and quantification of cytokines performed in animal models of immunization with native and irradiated mucus of Paratrygon aiereba, a large freshwater stingray. Antiserum potency and its cross-reactivity with mucus from other freshwater stingrays were detected by ELISA. Immunization models demonstrated the ability to stimulate a strong humoral response with elevated levels of serum IgG detectable by ELISA, and both native and irradiated mucus were immunogenic and capable of recognizing mucus proteins from other freshwater neotropical stingrays. Mucus P. aiereba causes cellular and humoral adaptive immune responses in cells of immunized mice producing antibodies and cytokines such as TNF-α, IL-6 and IL-17. Rabbit antisera immunized with mucus from P. aiereba irradiated at 2 kGy showed a significant reduction of mucus-induced edematogenic activity in mice. Our data suggest that the use of antisera against freshwater stingray mucus show the possibility of specific therapy for these accidents.
Collapse
Affiliation(s)
- Gabriela Ortega Coelho Thomazi
- Centro de Biotecnologia, Instituto de Pesquisas Energéticas e Nucleares, Universidade de São Paulo, Avenida Lineu Prestes, 2242, Cidade Universitária, CEP, 05508-000, São Paulo, SP, Brazil.
| | - Andrea da Costa
- Laboratório de Protozoologia, Instituto de Medicina Tropical de São Paulo, Universidade de São Paulo, Avenida Dr. Enéas Carvalho de Aguiar, 470, CEP, 05403-000, São Paulo, SP, Brazil.
| | - Jaqueline Polizeli Rodrigues
- Laboratório de Protozoologia, Instituto de Medicina Tropical de São Paulo, Universidade de São Paulo, Avenida Dr. Enéas Carvalho de Aguiar, 470, CEP, 05403-000, São Paulo, SP, Brazil.
| | - Glaucie Jussilane Alves
- Centro de Biotecnologia, Instituto de Pesquisas Energéticas e Nucleares, Universidade de São Paulo, Avenida Lineu Prestes, 2242, Cidade Universitária, CEP, 05508-000, São Paulo, SP, Brazil.
| | - José Pedro Prezotto Neto
- Centro de Biotecnologia, Instituto de Pesquisas Energéticas e Nucleares, Universidade de São Paulo, Avenida Lineu Prestes, 2242, Cidade Universitária, CEP, 05508-000, São Paulo, SP, Brazil.
| | - Thompson de Oliveira Turíbio
- Centro de Biotecnologia, Instituto de Pesquisas Energéticas e Nucleares, Universidade de São Paulo, Avenida Lineu Prestes, 2242, Cidade Universitária, CEP, 05508-000, São Paulo, SP, Brazil.
| | - André Moreira Rocha
- Centro de Biotecnologia, Instituto de Pesquisas Energéticas e Nucleares, Universidade de São Paulo, Avenida Lineu Prestes, 2242, Cidade Universitária, CEP, 05508-000, São Paulo, SP, Brazil.
| | - Raquel da Silva Aires
- Centro de Biotecnologia, Instituto de Pesquisas Energéticas e Nucleares, Universidade de São Paulo, Avenida Lineu Prestes, 2242, Cidade Universitária, CEP, 05508-000, São Paulo, SP, Brazil.
| | - Carla Simone Seibert
- Ciências do Ambiente, Campus de Palmas, Universidade Federal do Tocantins, Quadra 109 Norte, Avenida NS-15, ALCNO-14, Plano Diretor Norte, CEP, 77001-090, Palmas, TO, Brazil.
| | - Patrick Jack Spencer
- Centro de Biotecnologia, Instituto de Pesquisas Energéticas e Nucleares, Universidade de São Paulo, Avenida Lineu Prestes, 2242, Cidade Universitária, CEP, 05508-000, São Paulo, SP, Brazil.
| | - Andrés Jimenez Galisteo Júnior
- Laboratório de Protozoologia, Instituto de Medicina Tropical de São Paulo, Universidade de São Paulo, Avenida Dr. Enéas Carvalho de Aguiar, 470, CEP, 05403-000, São Paulo, SP, Brazil.
| | - Heitor Franco de Andrade Júnior
- Laboratório de Protozoologia, Instituto de Medicina Tropical de São Paulo, Universidade de São Paulo, Avenida Dr. Enéas Carvalho de Aguiar, 470, CEP, 05403-000, São Paulo, SP, Brazil.
| | - Nanci do Nascimento
- Centro de Biotecnologia, Instituto de Pesquisas Energéticas e Nucleares, Universidade de São Paulo, Avenida Lineu Prestes, 2242, Cidade Universitária, CEP, 05508-000, São Paulo, SP, Brazil.
| |
Collapse
|
5
|
de la Rosa G, Olvera F, Archundia IG, Lomonte B, Alagón A, Corzo G. Horse immunization with short-chain consensus α-neurotoxin generates antibodies against broad spectrum of elapid venomous species. Nat Commun 2019; 10:3642. [PMID: 31409779 PMCID: PMC6692343 DOI: 10.1038/s41467-019-11639-2] [Citation(s) in RCA: 43] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2018] [Accepted: 07/23/2019] [Indexed: 12/17/2022] Open
Abstract
Antivenoms are fundamental in the therapy for snakebites. In elapid venoms, there are toxins, e.g. short-chain α-neurotoxins, which are quite abundant, highly toxic, and consequently play a major role in envenomation processes. The core problem is that such α-neurotoxins are weakly immunogenic, and many current elapid antivenoms show low reactivity towards them. We have previously developed a recombinant consensus short-chain α-neurotoxin (ScNtx) based on sequences from the most lethal elapid venoms from America, Africa, Asia, and Oceania. Here we report that an antivenom generated by immunizing horses with ScNtx can successfully neutralize the lethality of pure recombinant and native short-chain α-neurotoxins, as well as whole neurotoxic elapid venoms from diverse genera such as Micrurus, Dendroaspis, Naja, Walterinnesia, Ophiophagus and Hydrophis. These results provide a proof-of-principle for using recombinant proteins with rationally designed consensus sequences as universal immunogens for developing next-generation antivenoms with higher effectiveness and broader neutralizing capacity.
Collapse
Affiliation(s)
- Guillermo de la Rosa
- Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México - UNAM, Apartado Postal 510-3, Cuernavaca Morelos, 61500, Mexico.
- The Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON, M5S3E1, Canada.
| | - Felipe Olvera
- Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México - UNAM, Apartado Postal 510-3, Cuernavaca Morelos, 61500, Mexico
| | - Irving G Archundia
- Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México - UNAM, Apartado Postal 510-3, Cuernavaca Morelos, 61500, Mexico
| | - Bruno Lomonte
- Instituto Clodomiro Picado, Universidad de Costa Rica, San José, 11501, Costa Rica
| | - Alejandro Alagón
- Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México - UNAM, Apartado Postal 510-3, Cuernavaca Morelos, 61500, Mexico
| | - Gerardo Corzo
- Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México - UNAM, Apartado Postal 510-3, Cuernavaca Morelos, 61500, Mexico.
| |
Collapse
|